SEC Form 4 · accession 0001077183-18-000149
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence Martin Weiss
Officer — Chief Scientific Officer
Period of report
Dec 12, 2018
Accepted (ET)
Dec 14, 2018 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.87 | Dec 12, 2018 | A | 25,000 | A | Dec 12, 2019 | Dec 12, 2023 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1On December 12, 2018, Dr. Weiss was granted an option to purchase shares of NeoGenomics, Inc. common stock. The option vests ratably over the first three anniversary dates of the grant date.